Stifel reiterated a Buy rating and $200 price target on Align Technology (ALGN), confirming that Angelalign will implement a price increase on January 1. The firm views the price increase as material to the stock, noting that while some specifics are a little unclear, it will take hold in the U.S., though it is less clear if it will be effective globally. An Angel price increase could further strengthen the case/appeal of Align’s pending “zero refinement” plan, which Stifel believes will be priced at roughly $850, with that list price now likely lower than Angelalign, the analyst tells investors in a research note. With Angel’s price now moving higher, the argument of Align Technology losing less share or winning back share should strengthen more, the analyst adds.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology announces commercial availability of Invisalign in Philippines
- Align Technology’s Earnings Call Highlights Growth Amid Challenges
- Early notable gainers among liquid option names on October 30th
- Align Technology price target raised to $170 from $160 at Evercore ISI
- Align Technology price target raised to $200 from $190 at Piper Sandler
